1245 related articles for article (PubMed ID: 33838206)
21. Oral erythema multiforme after Pfizer-BioNTech COVID-19 vaccination: a report of four cases.
Petruzzi M; Galleggiante S; Messina S; Della Vella F
BMC Oral Health; 2022 Mar; 22(1):90. PubMed ID: 35331228
[TBL] [Abstract][Full Text] [Related]
22. Viruses, Variants, and Vaccines: How COVID-19 Has Changed the Way We Look at Skin.
Singh R; Freeman EE
Curr Dermatol Rep; 2022; 11(4):289-312. PubMed ID: 36274754
[TBL] [Abstract][Full Text] [Related]
23. An Unusual Presentation of Erythema Multiforme Following the Administration of Pfizer-BioNTech COVID-19 mRNA Vaccine in a Pediatric Patient.
Alghamdi Y; Abdulghani F; Huwait HF; Abdulghani M; Samarkandy SJ
Cureus; 2024 Apr; 16(4):e58450. PubMed ID: 38765345
[TBL] [Abstract][Full Text] [Related]
24. Incidence and Characteristics of Delayed Injection Site Reaction to the mRNA-1273 Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccine (Moderna) in a Cohort of Hospital Employees.
Jacobson MA; Zakaria A; Maung Z; Hart C; McCalmont TH; Fassett M; Amerson E
Clin Infect Dis; 2022 Mar; 74(4):591-596. PubMed ID: 34086881
[TBL] [Abstract][Full Text] [Related]
25. Use of COVID-19 Vaccines After Reports of Adverse Events Among Adult Recipients of Janssen (Johnson & Johnson) and mRNA COVID-19 Vaccines (Pfizer-BioNTech and Moderna): Update from the Advisory Committee on Immunization Practices - United States, July 2021.
Rosenblum HG; Hadler SC; Moulia D; Shimabukuro TT; Su JR; Tepper NK; Ess KC; Woo EJ; Mba-Jonas A; Alimchandani M; Nair N; Klein NP; Hanson KE; Markowitz LE; Wharton M; McNally VV; Romero JR; Talbot HK; Lee GM; Daley MF; Mbaeyi SA; Oliver SE
MMWR Morb Mortal Wkly Rep; 2021 Aug; 70(32):1094-1099. PubMed ID: 34383735
[TBL] [Abstract][Full Text] [Related]
26. Cutaneous findings following COVID-19 vaccination: review of world literature and own experience.
Gambichler T; Boms S; Susok L; Dickel H; Finis C; Abu Rached N; Barras M; Stücker M; Kasakovski D
J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):172-180. PubMed ID: 34661927
[TBL] [Abstract][Full Text] [Related]
27. Safety Monitoring of Bivalent COVID-19 mRNA Vaccine Booster Doses Among Children Aged 5-11 Years - United States, October 12-January 1, 2023.
Hause AM; Marquez P; Zhang B; Su JR; Myers TR; Gee J; Panchanathan SS; Thompson D; Shimabukuro TT; Shay DK
MMWR Morb Mortal Wkly Rep; 2023 Jan; 72(2):39-43. PubMed ID: 36634021
[TBL] [Abstract][Full Text] [Related]
28. Delayed Cutaneous Hypersensitivity Reaction to Vaxzevria (ChAdOx1-S) Vaccine against SARS-CoV-2.
Sprute R; Schumacher S; Pauls M; Pauls W; Cornely OA
Drugs R D; 2021 Dec; 21(4):371-374. PubMed ID: 34351606
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous adverse reactions after COVID-19 vaccines in a cohort of 2740 Italian subjects: An observational study.
Grieco T; Maddalena P; Sernicola A; Muharremi R; Basili S; Alvaro D; Cangemi R; Rossi A; Pellacani G
Dermatol Ther; 2021 Nov; 34(6):e15153. PubMed ID: 34622531
[TBL] [Abstract][Full Text] [Related]
30. SARS-CoV-2 vaccine-related cutaneous manifestations: a systematic review.
Avallone G; Quaglino P; Cavallo F; Roccuzzo G; Ribero S; Zalaudek I; Conforti C
Int J Dermatol; 2022 Oct; 61(10):1187-1204. PubMed ID: 35141881
[TBL] [Abstract][Full Text] [Related]
31. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
Drago F; Broccolo F; Ciccarese G
Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
[TBL] [Abstract][Full Text] [Related]
32. COVID-19 vaccine-related presumed allergic reactions and second dose administration by using a two-step graded protocol.
Patel GB; Chhiba KD; Chen MM; Guo A; Watts MM; Cullen J; Bochner BS; Grammer LC; Greenberger PA; Saltoun CA; Stevens WW; Kuang FL; Peters AT
Allergy Asthma Proc; 2021 Nov; 42(6):515-521. PubMed ID: 34871159
[No Abstract] [Full Text] [Related]
33. Response to McMahon et al's "Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: A registry-based study of four hundred fourteen cases".
Poulas K; Farsalinos K
J Am Acad Dermatol; 2022 Apr; 86(4):e163-e164. PubMed ID: 34801633
[No Abstract] [Full Text] [Related]
34. An Argentinean cohort of patients with rheumatic and immune-mediated diseases vaccinated for SARS-CoV-2: the SAR-CoVAC Registry-protocol and preliminary data.
Isnardi CA; Schneeberger EE; Kreimer JL; Luna PC; Echeverría C; Roberts K; de la Vega MC; Virasoro BM; Landi M; Quintana R; Exeni MED; Kogan N; Petkovic I; Pereira D; De Los Ángeles Correa M; Zelaya MD; Tissera Y; Elkin MSG; Pisoni CN; Alonso C; Cogo AK; Cosatti MA; García L; Retamozo C; de Los Ángeles Severina M; Nieto RE; Rosemffet M; Mussano E; Bertoli A; Savio VG; Cosentino V; Pons-Estel GJ
Clin Rheumatol; 2022 Oct; 41(10):3199-3209. PubMed ID: 35760939
[TBL] [Abstract][Full Text] [Related]
35. Dermatological manifestations associated with COVID-19 and COVID-19 vaccination: results from the Lebanese COVID registry.
Chrabieh R; Haddad I; Salameh P; Kurban M; Kechichian E; Habre M; Ayoub N; Torbey G; El Sayed F; Maamari M; Tannous Z; Farra A; ; El Khoury J
Int J Dermatol; 2023 Oct; 62(10):1248-1256. PubMed ID: 37638543
[TBL] [Abstract][Full Text] [Related]
36. Management of coronavirus disease 2019 vaccine-induced cutaneous complications: A comprehensive literature review.
Bin Rubaian NF; Aljalfan AA; Almuhaidib SR
J Family Community Med; 2023; 30(3):161-170. PubMed ID: 37675215
[TBL] [Abstract][Full Text] [Related]
37. Vesiculobullous and Other Cutaneous Manifestations of COVID-19 Vaccines: a Scoping and Narrative Review.
Mahmood F; Cyr J; Li A; Lipson J; Pratt M; Beecker J
J Cutan Med Surg; 2023; 27(3):260-270. PubMed ID: 36789514
[TBL] [Abstract][Full Text] [Related]
38. Population-Based Incidence, Severity, and Risk Factors Associated with Treated Acute-Onset COVID-19 mRNA Vaccination-Associated Hypersensitivity Reactions.
Macy E; Pandya S; Sheikh J; Burnette A; Shi JM; Chung J; Gin N; Crawford W; Zhang J
J Allergy Clin Immunol Pract; 2022 Mar; 10(3):827-836. PubMed ID: 34971845
[TBL] [Abstract][Full Text] [Related]
39. Anaphylactic and nonanaphylactic reactions to SARS-CoV-2 vaccines: a systematic review and meta-analysis.
Alhumaid S; Al Mutair A; Al Alawi Z; Rabaan AA; Tirupathi R; Alomari MA; Alshakhes AS; Alshawi AM; Ahmed GY; Almusabeh HM; Alghareeb TT; Alghuwainem AA; Alsulaiman ZA; Alabdulmuhsin MA; AlBuwaidi EA; Dukhi AKB; Mufti HN; Al-Qahtani M; Dhama K; Al-Tawfiq JA; Al-Omari A
Allergy Asthma Clin Immunol; 2021 Oct; 17(1):109. PubMed ID: 34656181
[TBL] [Abstract][Full Text] [Related]
40. An observational study of adverse drug reactions to COVID-19 vaccines reported to the New Mexico poison center hotline.
Tadfor Y; Nguyen-Hua N; Bennett H; Bos AJ; Smolinske SC
Clin Toxicol (Phila); 2023 Jan; 61(1):77-83. PubMed ID: 36458888
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
